The US Food and Drug Administration (FDA) has cleared the FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system for adults and children ages 4 years and older with diabetes. The ...
Morning Overview on MSN
A new wearable tracks both blood sugar and ketones from a single sensor
People with diabetes who need to track both glucose and ketone levels have long juggled separate devices, pricking their ...
Freestyle-Libre-14-day_MPR-Image The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...
The US Food and Drug Administration has cleared the FreeStyle Libre 2 iOS application for use with compatible iPhones. The new app works with the FreeStyle Libre 2 with optional glucose alarms, which ...
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been linked to potential deaths.
FreeStyle Libre is a continuous glucose monitoring (CGM) system that allows a person to monitor their blood sugar levels in real time without finger pricks. It uses a sensor applied to the skin and a ...
CHICAGO (Reuters) - Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming ...
Health care giant Abbott issued a warning impacting four million readers for glucose monitors after reports that devices were overheating and catching fire when patients used non-Abbott charging cords ...
How Much Can Abbott's Price Gain If FreeStyle Libre Gets 30% of The Blood Glucose Monitoring Market?
Abbott Labs’ (NYSE:ABT) stock price could gain over 10% if its FreeStyle Libre system captures a 30% share of the blood glucose monitoring market by 2020, according to our estimates. FreeStyle Libre ...
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose readings.
Some users in the UK are experiencing a disruption in the functionality of the FreeStyle Libre 2 blood sugar monitoring app following an update, and it underscores the vulnerability of our digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results